• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Physicians Reveals GLP-1s for Weight Loss are Overprescribed and Unsustainable

by Jasmine Pennic 08/06/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Physicians Reveals GLP-1s for Weight Loss are Overprescribed and Unsustainable,

What You Should Know: 

– A large majority of physicians feel GLP-1s are being overprescribed, according to a new survey from Virta Health, a leader in type 2 diabetes reversal. 

– The Virta Health survey was conducted in partnership with Beresford Research and included 300 primary care providers, endocrinologists, and obesity specialists across the United States sheds light on the medical community’s views on the rapidly growing class of GLP-1 medications, often hailed as “miracle drugs” for weight loss. 

Key Findings Reveals Skepticism About Weight Loss Drugs

The key findings reveal significant concerns about the long-term efficacy, potential side effects, and overall impact of these medications on public health: 

– Doubtful about long-term efficacy: Most physicians believe GLP-1 medications are not sustainable beyond two to three years and should not be used as a long-term solution.

– Overprescription concerns: A large majority of physicians feel GLP-1s are being overprescribed and that lifestyle interventions should be prioritized.

– Need for stricter guidelines: Physicians advocate for increased oversight through prior authorization and greater provider involvement in prescribing decisions.

– Patient misconceptions: Many doctors report that patients have unrealistic expectations about the effectiveness and safety of GLP-1 medications.

– Potential for increased healthcare costs: The widespread adoption of GLP-1s is expected to drive up healthcare costs due to increased demand and limited supply.

– Concerns about health equity: Physicians are worried about the potential for increased health disparities as GLP-1 medications may not be equally accessible to all patients.

Alternative Approaches to Weight Management

The survey highlights the importance of comprehensive weight management programs that address both physical and psychological factors. Programs like Virta, which focuses on lifestyle changes and medical support, offer an alternative to medication-based approaches. By combining nutrition, exercise, and personalized coaching, Virta has helped patients achieve sustainable weight loss and improve overall health. The growing popularity of GLP-1 medications underscores the need for more rigorous research and data on their long-term effects and impact on public health. Healthcare providers must have access to comprehensive information to make informed decisions about treatment options for their patients.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Diabetes Management, Diabetes Management Platform, Diabetes Prevention Platform, GLP-1, Virta Health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |